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Abstract
Background: The screening of digital footprint for clinical purposes relies on the capacity of wearable technologies
to collect data and extract relevant information’s for patient management. Artificial intelligence (AI) techniques
allow processing of real-time observational information and continuously learning from data to build
understanding. We designed a system able to get clinical sense from digital footprints based on the smartphone’s
native sensors and advanced machine learning and signal processing techniques in order to identify suicide risk.
Method/design: The Smartcrisis study is a cross-national comparative study. The study goal is to determine the
relationship between suicide risk and changes in sleep quality and disturbed appetite. Outpatients from the
Hospital Fundación Jiménez Díaz Psychiatry Department (Madrid, Spain) and the University Hospital of Nimes
(France) will be proposed to participate to the study. Two smartphone applications and a wearable armband will
be used to capture the data. In the intervention group, a smartphone application (MEmind) will allow for the
ecological momentary assessment (EMA) data capture related with sleep, appetite and suicide ideations.
Discussion: Some concerns regarding data security might be raised. Our system complies with the highest level of
security regarding patients’ data. Several important ethical considerations related to EMA method must also be
considered. EMA methods entails a non-negligible time commitment on behalf of the participants. EMA rely on
daily, or sometimes more frequent, Smartphone notifications. Furthermore, recording participants’ daily experiences
in a continuous manner is an integral part of EMA. This approach may be significantly more than asking a
participant to complete a retrospective questionnaire but also more accurate in terms of symptoms monitoring.
Overall, we believe that Smartcrises could participate to a paradigm shift from the traditional identification of risks
factors to personalized prevention strategies tailored to characteristics for each patient.
Trial registration number: NCT03720730. Retrospectively registered.
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Background
Suicide risk and monitoring
Over 800,000 people die because of suicide every year
worldwide. For each suicide, there may have been
more than 20 other attempted suicides. A previous
attempt is the major predictor of death by suicide [1].
However, many other outcomes associated with
suicidal behaviors should be considered in order to
strength preventative strategies prevention. Environ-
mental, Clinical, and genetic [2] risk factors have
been intensively studied among suicide attempters in
order to improve personalization and effectiveness of
preventative programs [3]. Suicide risk assessment re-
lies on standard follow-up outpatient visits in a psy-
chiatric clinic. This assessment includes a mental
status examination, a brief update on the history of
the patient’s present illness (including a safety assess-
ment of risk of self-harm, suicide). In order to de-
velop a form of assessment that can more accurately
track patients’ symptoms and risks between visits, we
conducted several studies aiming to add ecological
momentary assessment to traditional follow up strategies
[4] [5]. Advances in sensors technology, and artificial
intelligence methods (AI) also draw new perspectives for
behavior ecological assessment [6]. Sleep disturbances and
food intakes are not one of suicide risk factors usually
screened in routine suicide risk monitoring [7].Yet this
clinical information could play a central role in suicide
risk identification and prediction.
Sleep, eating disorders and suicide risk
Sleep loss and sleep disturbances are associated with
an increased risk of suicidal behavior, including sui-
cidal ideation, suicide attempt, and completed suicide
[8]. This relationship is consistent across psychiatric
diagnoses and age groups [9]. The increased risk of
suicidal ideation and suicide attempts among patients
with early or late awakening times was demonstrated
in representative samples of Korean [10] and British
[11] adolescents of both genders. Chui et al. observed
in a pooled sample of adolescents a linear dose–re-
sponse relationship between sleep duration and sui-
cide plans [12]. Rossler et al. showed that the
correlates between sleep disorders including short
sleep duration and suicidality was also observed in
adults [13]. In a 30-year longitudinal cohort study of
adults people, authors showed that the more severe
the sleep problems are, the more pronounced is sui-
cidality, including suicide ideation and behaviours.
Interestingly these patterns persist even if we control
for socio-demographics and in particular for accom-
panying mood, anxiety, or substance-use disorders,
[14]. Changes in appetite are closely connected with
depressive symptomatology and suicidal behavior [15].
Appetite has already been used in the prediction of
suicidal risk [16]. Regarding eating disorders, negative
self-image variables have been associated with suicide
attempt history in anorexia and suicide attempts com-
pletions in women with bulimia [17]. In fact, in a co-
hort study of eating disordered subjects, the risk for
suicide attempt was 4.70 (95% CI 1.41–15.74) in pa-
tients with eating disorders compared to matched
(age, sex, place of residence) general population con-
trols and further increased to 11.30 (95% CI 6.90–
18.50) in those patients with history of previous sui-
cide attempt [18]. A recent study found that suicide
attempters had lower body mass index (BMI) and
waist circumference, as well as decreased levels of
serum [19].
Suicide risk management in the e-health era
The integration of smartphones and wearables into med-
ical practice has heralded the electronic-health (e-health)
era. E-health involves the integration of new technolo-
gies into routine clinical practice by increasing network-
ing possibilities between patients and clinicians. Recent
trials using mobile electronic devices have proven suc-
cessful in real-world and real-time monitoring and have
improved the assessment possibilities in a large panel of
clinical settings [20]. The assessment of the patient’s dy-
namic relationships between events and disease course is
enhanced by the development of momentary data collec-
tion strategies, such as experience sampling methods
(ESM) and ecological momentary assessment (EMA)
[21]. These approaches, which rely on delivering inform-
ative contents and self-administered questionnaires, re-
duce the recall bias as they are done in real time [22].
Electronic devices are also able to perform passive (or
autonomous) data gathering, i.e., to extract information
about the users without any effort on their part. Actigra-
phy, geolocation, and communication activity are usual
features of current smartphones and may be indicators
of the patient’s behavior if they are properly processed.
Overall, an extensive panel of physical and mental con-
ditions can be remotely monitored [23]. Smartphones
can embody such sensors and provide EMA features
relying on patient self-reports. Finally, the data digital
footprints, which is the automatically accumulated by-
products of technological devices, offer a promising op-
portunity for research and clinical decision making [24].
The collected data can be processed and transferred
over the Internet to a remote clinical back-end server
for further analysis, assessment, decision making and
intervention. AI is a set of analysis methods which per-
mits to extract relevant information from any dataset. AI
uses data mining techniques to get sense for the data. a
set of techniques that can be used to explore treatment
and outcome questions in large clinical databases and
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help develop algorithms and guidelines for problems
where controlled data are difficult to obtain. The data
mining process includes several steps, including data
capture, data selection, data processing, and machine
learning. Abdullah et al. reported that combining self-re-
ported data with data from several smartphone sensors
and communication patterns resulted in reliable predic-
tion of the Social Rhythm Metric, a clinically-validated
marker of stability and rhythmicity for individuals with
bipolar disorder [25] Voice features from phone calls
can also be collected and analyzed during everyday life
in naturalistic settings. For inferring rhythmicity, a key
marker of wellbeing for individuals with bipolar disorder.
Another platform proposed A method to predict schizo-
phrenia based on anomaly detection was developed
using Beiwe, a platform able to perform data mining on
smartphone data [26]. EMA has been successfully used
for real-time self-reporting of symptoms and behavior—
for example, Husky et al. showed the utility and feasibil-
ity of using EMAs to study suicidal ideations [27].
Taking into account the strengths and pitfalls of exist-
ing suicide risk assessment methods, we have designed a
system capable to combine EMA and continuous moni-
toring of patients using the smartphone’s and/or wear-
able’s sensors and data entry in order to monitor and
predict suicide risk. Both poor sleep quality and dis-
turbed appetite are clinical markers of depression, with a
bidirectional relationship. Their changes could precede
the increase of suicidal behavior as sleep and appetite
are both influenced by mood state and regulated by the
serotonergic system. Our hypothesis is that tracking
sleep and appetite regularly through self-report could
serve as a consistent and non-biased shortcut to assess
mood state, its biological underpinnings and could po-
tentially predict suicidal behavior.
Objectives
The overall study goal is to determine the relationship
between wish to die, and suicide attempt and changes in
sleep quality and disturbed appetite using Smartphone
and wearable technology based using ecological mo-
mentary assessment (EMA).
The principal objective of the study is to identify the
correlation between quality of sleep monitored via the
digital footprint and suicidal events including and sui-
cide attempts in a cohort of suicidal patients.
Secondary objectives are:
 Establish the extent to which change in appetite is
related to and suicide attempts.
 Clarify the timeline of the relationship between sleep
disturbances and suicidal behavior.
 Determine the emotional impact of the use of the
app during suicide related outcomes assessed.
 Develop personalized algorithms based on the EMA
protocol and motor activity markers to assess the
risk of suicide attempts.
Method and design
Study design and setting
This study is a pragmatic, prospective, multisite con-
trolled trial with two parallel groups. The study setting
is outpatient clinics and emergency departments at four
clinical centers across two countries (Jimenez Diaz
Foundation, Spain, University Hospital of Nimes,
France).
Participants
To be eligible for the study, patients must be 18 years or
older, attend an outpatient clinic or emergency depart-
ments of participating clinical services and owning an
android or IOS smartphone. Exclusion criteria are being
less than 18 years old, refusal to participate to the study,
and patients and in emergency situations where their
state of health does not allow obtaining written consent.
Patients who are unable or unwilling to provide in-
formed and signed consent will be also excluded.
This study was built on the results of previous studies
we conduced exploring the preferences of patient re-
garding eHealth based suicide assessment [28, 29]. Pa-
tients were involved in the design of this study in a
preliminary step of the application conception which
assed the feasibility and the burden of such approach in
a sample of outpatients [30]. Patient were informed they
could have access to the final result of the study during
a routine medical visit, according to the ethic committee
query.
Intervention and control
After agreeing to participate, clinician will collect a
signed consent for each patient. Patient will be assigned
to intervention or control group weather they have a
personal history of suicide attempt or not. Patient with a
current suicidal behavior disorder (according to DSM-5),
i.e. having attempted suicide in the current year, will be
assigned to the intervention group.
Patient with no history of suicide behavior will be
assigned to the control group. Both intervention and
control group will receive as usual follow up. monitoring
visits. In the intervention group, each participant will be
assessed with an EMA protocol using two smart phones
apps. The first app will ask questions following a dy-
namic protocol (quality and duration of sleep, wish to
live and wish to die, and questions regarding emotional
status), the second app will record diurnal activity that is
related with sleep quality using smartphone sensors.
Additionally, a subsample of participants of the interven-
tion group will be monitored with a wearable armband
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to assess sleep phases and physiological changes during
sleep and EMA assessment. Control group will only re-
ceive as usual follow up procedure and monitoring pro-
cedure of the study protocol (see Fig. 1).
Primary outcome
The primary outcomes are suicidal events assessed by
Columbia-Suicide Severity Rating Scale (C-SSRS) in con-




Evaluate appetite using the Council of Nutrition Appetite
Questionnaire (CNAQ) score with EMA questions.
Sleep duration before and after a suicide attempt in
intervention group during the 6-month follow-up
period.
Electrodermal activity captured by waerables during
EMA assessment in the intervention group.
Pooled EMA data Suicidal events and eating disorders
in control and intervention group during the 6-month
follow-up period.
Digital collection, and data analysis
The “Smartcrises” platform is composed by two smart-
phone apps, which collect EMA data and smartphone
sensors data, and a back-end server, which stores and
processes them.
EB2 app
The eB2 app collects data from inertial sensors, physical
activity, phone calls and message logs, app usage, nearby
Bluetooth and Wi-Fi connections, and location. Also,
using Google Play Services, the app is able to access de-
tailed activity information and nearby location data. The
app was developed to run in background and the user
only interacts with the app for the initial configuration.
Moreover, it was designed with battery safe consider-
ations like non-continuous recording schedule, auto-
matic sleep/wake function, and it additionally notifies
Fig. 1 Patient flow in intervention group and control group
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the operating system to relaunch itself when it was
closed or stopped due to user’s actions or failures/
reboots.
Memind app
Memind is a smartphone application able to perform
EMA. The MEmind app will assess wish to die via a self
questionnaire and a computer assisted algorithm. The
type and amount of food intake will be evaluated
through the dynamic questions. Participants will be
asked four static questions in the morning and evening
while dynamic questions will be asked randomly at any
one time-point during the day (at most 4 random ques-
tions from a pull of 32 questions distributed throughout
the day). This application will offer questions on the
quantity and quality of sleep, appetite and food intake,
on the occurrence of social stress, evaluation of suicidal
ideas and emotions. These questions are displayed ac-
cording to a nonlinear dynamic model during participa-
tion to the study [31].
Data collection and follow-up
Baseline assessment
The baseline enrolment questionnaire includes the pa-
tient’s basic demographic information including age,
gender, marital status, employment status, country of
birth, language spoken at home, level of education and
whether they had a regular general practitioner.
Medical treatments at inclusion, as well as any changes
in these treatments during follow-up, will be collected
and analyzed as potential confounders. The treatments
will be classified according to the classification estab-
lished by the World Health Organization (ATC index).
The entire lifetime diagnosis of mental disorders axis I
and II according to DSM-5 will be based on existing
clinical evaluation protocols at inclusion: Mini Inter-
national Neuropsychiatric Interview 7.0.0. Participants
will be evaluated for depressive symptomatology [32], to
detect the possibility of a manic episode [33] and to
evaluate their global functioning [34].
Outcomes measures
We will use complementary strategies to obtain the pri-
mary outcome measures and assess adverse events. As-
sessments will be carried out by trained clinicians
(Psychologist, Psychiatrist or Psychiatrist Residents up to
second year) at outpatient clinics and emergency
departments.
Researchers will check the hospital attendance data es-
pecially the emergency records.
The assessment of suicidal behaviors will include at
the inclusion and completion of follow-up:
 The Columbia Suicide Severity Rating Scale a scale
that showed good sensitivity and specificity to
identify the most at risk subjects [35].
 If a suicide attempt has occurred, the suicide intent
scale [36] and the Risk Rescue Rating Scale.
Suicide and sleep monitoring
Evaluation of the principal objective will be monitored
via in-person interviews (see baseline assessment subsec-
tion) and EMA self-questionnaires including wish to live,
wish to die, suicidal ideation, and suicide attempt during
the follow-up period. The Suicidal Status Form [37] the
Perceived Social Support Questionnaire (PSSQ,) and the
Interpersonal Needs Questionnaire [38] have been incor-
porated into pop-ups to our EMA app to increase the
participation rate during inactive periods [31].
The MEmind App will provide questions following a
dynamic smartphone based assessment protocol explor-
ing quality of sleep. The EB2 app will record diurnal ac-
tivity that is related with sleep quality using smartphone
sensors. EB2 will be validated with polysomnographic
registers (see Fig. 2). EB2 is designed to collect informa-
tion about the users’ physical and physiological activity
level. This application has been developed for the An-
droid mobile platform and works in combination with
the arm Band. SmartPhone and the arm Band communi-
cate via Bluetooth 4.0. This application obtains informa-
tion from the user by accessing the built-in sensors in
the host Android SmartPhone and the arm Band.
Through the process of data logging the Sensor Logger
APP records both the information from the SmartPhone
and arm Band. This double recording of information by
the Sensor Logger APP allows it to obtain enough infor-
mation from inertial sensors to determine the user’s ac-
tivity level during the recording process [39]. The heart
rate signal and Galvanic skin response are also recorded
to determine the emotional state of the user. In our
study participants in the Smartcrisis group will be moni-
tored with a wearable armband to assess sleep phases
and physiological changes during sleep.
Food intake monitoring
Two questions in the dynamic protocol will assess appe-
tite and food intake. Food ingestion will also be assessed
and paired with activity monitoring using the arm band
data.
Emotional state during EMA process
The wearable tracker band will record electrodermal activ-
ity at 3 time points: 5 min prior to EMA questioning; dur-
ing the patient answer to EMA and 5min after. Objective
longitudinal records from patients will determine the
sleep-suicide behavior casual chain based on wearables
and EMA records.
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Sample size
We propose to recruit 1000 patients from two sites and
expect a total of 100 suicide re-attempts during the fol-
low-up period. We plan to recruit 500 patients per site
(total of 1000) during 18months with a follow-up period
of 6 months. Based on our suicidal behavior monitoring
pilot data (see above), we have calculated power in
multivariate logit regression models, assuming a type I
error of 0.05 and two-sided comparison. Using the effect
sizes and standard deviations from our pilot data we ex-
pect our sample 1000 attempters and 100 reattempters
during the follow-up) to provide 80% power to detect
significant changes in death desire, suicidal ideation or
suicide attempt related with sleep and appetite.
Data analysis
We will carry out descriptive analyses of all data col-
lected separately by site and treatment. We will calculate
means, variances and empirical quartiles, and assess the
distribution and skewness of the data. If groups differ
significantly on covariates then these scores will
additionally be included as covariates in multivariate re-
gression models.
We will use 3 multi-level logit regression to account
for multiple observations per individual, to identify indi-
vidual-level (sleep, appetite, socio-demographic, clinical
data, treatment data) and site-level characteristics associ-
ated with death desire, suicidal ideation or suicide at-
tempt. We will use hazards models to relate covariate
characteristics (sleep, appetite, socio-demographic, clin-
ical data, treatment data) with time to suicide re-attempt
during the follow-up period. Data mining (machine
learning) techniques will be used to examine risk factors,
patterns of illness evolution and outcomes, and patient
stratification by level of risk.
Discussion
Data privacy
Data privacy is a serious concern in the e-health re-
search area. Our system complies with the highest level
of security regarding patients’ data. The eB2 app cap-
tures data from smartphones, which possibly was a
Fig. 2 Patient flow in intervention group
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deterrent for patients to accept the app [40]. In a prelim-
inary study, patients were aware of the general approach
of our method and were not very concerned about shar-
ing their personal data since it was anonymized at the
smartphone. Another major concern regarding personal
electronic data is data security [41]. In order to preserve
the patient’s privacy and reduce the risk associated to a
non-legitimate access, all the sensible information stored
in the eB2 server was hashed and anonymized. Phone
numbers, email addresses, Bluetooth, and Wi-Fi MAC
addresses were hashed using the SHA-1 algorithm and
the location was transformed using a non-invertible
function. We store randomly-rotated relative location
coordinates, where the origin was the location that was
most common during the first three days after installa-
tion (typically the patient’s home). Our apps are available
via app stores, which allows us to continuously update
and improve the app based on newly discovered bugs
and also user feedback. However, the access to the apps
contents and features is permitted only for patients
accepting to participate to the study. All online self-re-
port data are de-identified (identified by a random code,
unrelated to any data protected by HIPAA). Only the PI
holds the code, stored in a secure location separate from
data. Personal information about potential and enrolled
participants will be collected, and maintained in order to
protect confidentiality before, during, and after the trial
according to the terms described in the ethic committee
report. These data will can be used for anciliary analysis
after the study manuscript publication. Data will only be
shared by the cited authors of this manuscript. Data will
be anonymized before communication to other research
office members .
The burden of EMA method
Other important ethical are related to EMA method must
also be considered. The matter of participant burden is
one such issue. EMA methods entails a non-negligible
time commitment on behalf of the participants. EMA rely
on daily, or sometimes more frequent, Smartphone notifi-
cations. Notifications produce a significant increment in
verified compliance when compared with an identical trial
without notification. A significant eroding of compliance
can be observed after 3 weeks of ecological assessment
[42]. Furthermore, recording participants’ daily experi-
ences in a continuous manner is an integral part of EMA.
This approach may be significantly more invasive than
asking a participant to complete a retrospective question-
naire or answering a question at a traditional interview
[43]. The risk of intrusiveness into daily life is real. Receiv-
ing notifications may also inconvenience participants who
are expected to complete an EMA or read information at
a moment’s notice (ie, requests may occur at inopportune
times).
A paradigm shift in suicide risk prevention
This study stands out from randomized controlled trials or
observational studies ailing to identify suicide risk factors.
We conducted a preliminary study showing that the eB2
system was capable of identifying mobility pattern
changes, which may be used as proxies for behavioral
changes and relapses in mental health [6]. We will apply
the two key type of models previously tested in suicidal
prediction: 1) predictive models or discriminative models
and 2) explanatory or generative models. Both predictive
and explanatory models use patient features to provide in-
formation on future events, such as the likelihood that a
patient will attempt suicide in a given time interval. Ap-
plying these models to our database, will generation of
tools to improve medical decision-making, patient out-
comes, and to identify mediators and moderators within
causal pathways. We will also develop latent feature
models using Nonparametric Bayesian (NPB) approaches
to detect the different predictive signatures. The central
idea behind nonparametric Bayes (NPB) is the replace-
ment of the classical finite-dimensional prior distributions
with general stochastic processes, allowing an open-ended
number of degrees of freedom in a model. Nonparametric
priors have several properties that make them desirable to
model data with an unknown number of characteristics of
different sizes or importance.
Overall, we believe that “Smartcrises” could participate
to a paradigm shift from the traditional identification of
risks factors in mental illnesses to personalized preven-
tion strategies tailored to characteristics for each patient,
i.e., personalized medicine [44]. We have developed a
system that is able to capture data from the smart-
phone’s native sensors and other wearables. AI tech-
niques seek to answer the question: How can we build
computer systems that automatically improve with ex-
perience, and what are the fundamental laws that govern
all learning processes? Machine learning techniques
allow processing of real-time observational information
by continuously learning from data to build understand-
ing and uncover previously unexpected associations and
patterns in data. Predictive and explanatory models
might use individual patient data to predict future events
like the probability of a patient attempting suicide in a
given time interval. Our final goal would be the identifi-
cation of more general behavioral changes (online social
interaction) in outpatients, which has important applica-
tions for a wide range of chronic conditions, including
mental health disorders. Apart from the continuous as-
sessment of bio-parameters themselves, smartphone-
based monitoring would also allow researchers to gather
information on context and environment, which may
prove valuable for the interpretation of the monitored
biomedical data and allow for a better preventative
approaches.
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